Log in to save to my catalogue

Efficacy and safety of bevacizumab in elderly patients with metastatic colorectal cancer: results fr...

Efficacy and safety of bevacizumab in elderly patients with metastatic colorectal cancer: results fr...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3987650

Efficacy and safety of bevacizumab in elderly patients with metastatic colorectal cancer: results from the Czech population-based registry

About this item

Full title

Efficacy and safety of bevacizumab in elderly patients with metastatic colorectal cancer: results from the Czech population-based registry

Publisher

England: BioMed Central

Journal title

BMC gastroenterology, 2014-03, Vol.14 (1), p.53-53, Article 53

Language

English

Formats

Publication information

Publisher

England: BioMed Central

More information

Scope and Contents

Contents

Patients aged 65 years and older represent the majority of patients with metastatic colorectal cancer (mCRC). However, this patient population is often underrepresented in clinical trials and probably undertreated in the clinical practice.
We have analysed the outcomes of 3,187 mCRC patients treated with first-line bevacizumab based on data from...

Alternative Titles

Full title

Efficacy and safety of bevacizumab in elderly patients with metastatic colorectal cancer: results from the Czech population-based registry

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3987650

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3987650

Other Identifiers

ISSN

1471-230X

E-ISSN

1471-230X

DOI

10.1186/1471-230X-14-53

How to access this item